{
  "What is the details overview and overview history of the company with CIK 1168165 in 2018?": [
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "2019 (incorporated by reference to Exhibit 10.176 of the Company\u2019s Current Report on Form 8-K filed with the SEC on October 2, 2019). 10.86 Exchange Agreement, dated as of December 23, 2019, between Rennova Health, Inc. and Alcimede LLC (incorporated by reference to Exhibit 10.177 of the Company\u2019s Current Report on Form 8-K filed with the SEC on December 27, 2019). 10.87 Form of Promissory Note, with Evolve Bank & Trust (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on May 12, 2020). 10.88 Exchange Agreement, dated as of June 30, 2020, between Rennova Health, Inc. and Christopher Diamantis (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on July 8, 2020). 10.89 Voting Agreement and Irrevocable Proxy, dated as of August 13, 2020, by and among Rennova Health, Inc., Seamus Lagan, Alcimede LLC and Christopher Diamantis (incorporated by reference to the Company\u2019s Quarterly",
      "similarity": 0.5336249225443876
    },
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "Financial Statements and ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. __________ (a) The 2016 financial results include the activity of PHI from the merger effective date of March 24, 2016 through December 31, 2016. (b) On April 1, 2014, Generation assumed operational control of CENG’s nuclear fleet. As a result, the 2014 financial results include CENG’s results of operations on a fully consolidated basis. (c) Amounts have been recasted to reflect the Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost guidance adopted as of January 1, 2018. See Note 1 - Significant Accounting Policies of the Combined Notes to Consolidated Financial Statements for additional information. (d) Amounts for 2017 and 2016 have been recasted to reflect the Revenue from Contracts with Customers guidance adopted as of January 1, 2018. See Note 1 - Significant Accounting Policies of the Combined Notes to",
      "similarity": 0.5217211194750022
    },
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "financial reporting as of December 31, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO. Basis for Opinions The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management‚Äôs Report on Internal Control Over Financial Reporting appearing under Item 8. Our responsibility is to express opinions on the Company‚Äôs consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange",
      "similarity": 0.5188395744510017
    }
  ],
  "What is the unresolved overview and comments history of the company with CIK 1046025 in 2018?": [
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "2019 (incorporated by reference to Exhibit 10.176 of the Company\u2019s Current Report on Form 8-K filed with the SEC on October 2, 2019). 10.86 Exchange Agreement, dated as of December 23, 2019, between Rennova Health, Inc. and Alcimede LLC (incorporated by reference to Exhibit 10.177 of the Company\u2019s Current Report on Form 8-K filed with the SEC on December 27, 2019). 10.87 Form of Promissory Note, with Evolve Bank & Trust (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on May 12, 2020). 10.88 Exchange Agreement, dated as of June 30, 2020, between Rennova Health, Inc. and Christopher Diamantis (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on July 8, 2020). 10.89 Voting Agreement and Irrevocable Proxy, dated as of August 13, 2020, by and among Rennova Health, Inc., Seamus Lagan, Alcimede LLC and Christopher Diamantis (incorporated by reference to the Company\u2019s Quarterly",
      "similarity": 0.538741260116427
    },
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "customers in portions of southern New Jersey. This segment is discussed in further detail in ITEM 1. BUSINESS - ACE of this Form 10-K. Executive Overview A discussion of items pertinent to ACE‚Äôs executive overview is set forth under EXELON CORPORATION - Executive Overview of this Form 10-K. Results of Operations Year Ended December 31, 2018 Compared to Year Ended December 31, 2017 and Year Ended December 31, 2017 Compared to Year Ended December 31, 2016 A discussion of ACE‚Äôs results of operations for 2018 compared to 2017 and for 2017 compared to 2016 is set forth under Results of Operations-ACE in EXELON CORPORATION - Results of Operations of this Form 10-K. Liquidity and Capital Resources ACE‚Äôs business is capital intensive and requires considerable capital resources. ACE‚Äôs capital resources are primarily provided by internally generated cash flows from operations and, to the extent necessary, external financing, including the issuance of long-term debt, commercial paper or credit",
      "similarity": 0.5270072825736917
    },
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "ended December 31, 2020, and the related notes (collectively referred to as the \u201cfinancial statements\u201d). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (\u201cPCAOB\u201d), the Company\u2019s internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (\u201cCOSO\u201d), and our report dated February 23, 2021 expressed an unqualified opinion. Basis for opinion These financial statements are the responsibility of",
      "similarity": 0.5206414399664767
    }
  ],
  "What is the risk overview and investment history of the company with CIK 1046025 in 2018?": [
    {
      "cik": 1282224,
      "year": 2020,
      "section": "section_7",
      "chunk_text": "Mid-Atlantic, Midwest, New England, New York, ERCOT and Other Power Regions. These segments are discussed in further detail in ITEM 1. BUSINESS - Exelon Generation Company, LLC of this Form 10-K. Executive Overview A discussion of items pertinent to Generation‚Äôs executive overview is set forth under ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Exelon Corporation - Executive Overview of this Form 10-K. Results of Operations Year Ended December 31, 2018 Compared to Year Ended December 31, 2017 and Year Ended December 31, 2017 Compared to Year Ended December 31, 2016 A discussion of Generation‚Äôs results of operations for 2018 compared to 2017 and 2017 compared to 2016 is set forth under Results of Operations-Generation in EXELON CORPORATION - Results of Operations of this Form 10-K. Liquidity and Capital Resources Generation‚Äôs business is capital intensive and requires considerable capital resources. Generation‚Äôs capital resources are",
      "similarity": 0.5843704419490511
    },
    {
      "cik": 1559720,
      "year": 2020,
      "section": "section_7",
      "chunk_text": "Item 7. Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section titled \u201cRisk Factors\u201d or in other parts of this Annual Report on Form 10-K. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. Except as otherwise noted, all references to 2020 refer to the year ended December 31, 2020, references to 2019 refer to the year ended December 31, 2019, and references to 2018",
      "similarity": 0.5543649161912237
    },
    {
      "cik": 1742491,
      "year": 2019,
      "section": "section_7",
      "chunk_text": "ITEM 7.MANAGEMENT\u2019S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS This annual report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as \u201canticipate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cwill,\u201d \u201cwe believe,\u201d \u201cmanagement believes\u201d and similar language. Except for the historical information contained herein, the matters discussed in this \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d and elsewhere in this current report on Form 10-K are forward-looking statements that involve risks and uncertainties. The factors listed in the section captioned \u201cRisk Factors,\u201d as well as any cautionary language in this current report on Form 10-K, provide examples of risks, uncertainties and events that may cause our actual results to differ materially",
      "similarity": 0.5517882429236383
    }
  ],
  "What properties does the company with CIK 1046025 operate in 2018?": [
    {
      "cik": 1493976,
      "year": 2018,
      "section": "section_15",
      "chunk_text": "2018, we acquired the four operating properties listed below in two transactions from unrelated third parties. We did not acquire any operating properties during the year ended December 31, 2017. ________________________ (1) Excludes acquisition-related costs. F - 26 KILROY REALTY CORPORATION AND KILROY REALTY, L.P. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (2) At December 31, 2018, this property was temporarily being held in a separate VIE to facilitate potential Section 1031 Exchanges. During January 2019, the Company completed the Section 1031 Exchange related to this VIE. See Note 2 \u201cBasis of Presentation and Significant Accounting Policies.\u201d (3) The results of operations for the properties acquired during 2018 contributed $8.0 million and $1.7 million to revenue and net income, respectively, for the year ended December 31, 2018. The related assets, liabilities and results of operations of the acquired properties are included in the consolidated financial statements",
      "similarity": 0.5016506435938572
    },
    {
      "cik": 1071840,
      "year": 2019,
      "section": "section_10",
      "chunk_text": "Properties Ltd., a privately owned 50-year old real estate holding and development company involved with award winning heritage building restorations and ground-up residential and office developments. Omicron Development Inc. and Reliance Properties Ltd. are not affiliated with SolarWindow Technologies, Inc. Mr. Horvitz has not served as a director of a public company or any company registered as an investment company in the past 5 years. Gary P. Parmar, CPA, CA. Mr. Parmar is a Partner and Regional Leader of Technology Media Telecommunications with MNP, a leading Canadian national accounting, tax and business consulting firm. Based in Kelowna, Gary provides accounting, tax, financial planning and business management advice to private enterprises and family-owned businesses, helping them increase profits, grow their operations and achieve their goals. With more than 20 years of experience, Gary understands his clients\u2019 unique challenges and delivers creative solutions that help them",
      "similarity": 0.48473977232650767
    },
    {
      "cik": 1456857,
      "year": 2018,
      "section": "section_15",
      "chunk_text": "infrastructure development - currently in the Las Vegas market. It is our intention to grow our business and provide a 360-degree spectrum of infrastructure (including: cultivation, production management, dispensaries and consulting services) through: the acquisition of existing companies; joint ventures with existing companies possessing complementary expertise, and/or through the development of new opportunities. (See Subsequent Events for highlights of major events subsequent to December 31, 2018) We were incorporated on November 17, 2006, as Securitas EDGAR Filings, Inc. under the laws of the State of Nevada on February 14, 2014, we amended and restated our Articles of Incorporation and changed our name to MJ Holdings, Inc. From February 2014 to January 2017, we owned and leased real estate properties zoned for legalized marijuana operations to licensed marijuana operators. On November 22, 2016, in connection with a plan to divest ourselves of our real estate business, we",
      "similarity": 0.4752654843730132
    }
  ],
  "What is the business overview and operation history of the company with CIK 1046025 in 2018?": [
    {
      "cik": 931059,
      "year": 2020,
      "section": "section_15",
      "chunk_text": "Report on Form 10-Q filed with the SEC on August 13, 2020). 10.90 Form of Exchange, Redemption and Forbearance Agreement, dated as of August 31, 2020, among Rennova Health, Inc., Christopher Diamantis and the investor signatory thereto (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on September 1, 2020). List of Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 of the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on October 21, 2019). 23.1 Consent of Independent Public Accounting Firm - Haynie & Company (2) 31.1 Section 302 Certification of the Chief Executive Officer (2) 31.2 Section 302 Certification of the Interim Chief Financial Officer (2) 32.1 Section 906 Certification of the Chief Executive Officer (3) 32.2 Section 906 Certification of the Interim Chief Financial Officer (3) 101.INS XBRL Instance Document. (2) 101.SCH XBRL Taxonomy Extension Schema",
      "similarity": 0.5441467224442643
    },
    {
      "cik": 1168165,
      "year": 2018,
      "section": "section_1B",
      "chunk_text": "Financial Statements and ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. __________ (a) The 2016 financial results include the activity of PHI from the merger effective date of March 24, 2016 through December 31, 2016. (b) On April 1, 2014, Generation assumed operational control of CENG\u2019s nuclear fleet. As a result, the 2014 financial results include CENG\u2019s results of operations on a fully consolidated basis. (c) Amounts have been recasted to reflect the Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost guidance adopted as of January 1, 2018. See Note 1 - Significant Accounting Policies of the Combined Notes to Consolidated Financial Statements for additional information. (d) Amounts for 2017 and 2016 have been recasted to reflect the Revenue from Contracts with Customers guidance adopted as of January 1, 2018. See Note 1 - Significant Accounting Policies of the Combined Notes to",
      "similarity": 0.5411014962407044
    },
    {
      "cik": 202584,
      "year": 2018,
      "section": "section_15",
      "chunk_text": "appearing in this Annual Report on Form 10-K of Entergy Texas, Inc. for the year ended December 31, 2018. We consent to the incorporation by reference in Registration Statement No. 333-213335-04 on Form S-3 of our report dated February 26, 2019, relating to the financial statements of System Energy Resources, Inc. appearing in this Annual Report on Form 10-K of System Energy Resources, Inc. for the year ended December 31, 2018. /s/ DELOITTE & TOUCHE LLP New Orleans, Louisiana February 26, 2019 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the shareholders and Board of Directors of Entergy Corporation and Subsidiaries Opinion on the Financial Statement Schedule We have audited the consolidated financial statements of Entergy Corporation and Subsidiaries (the \u201cCorporation\u201d) as of December 31, 2018 and 2017, and for each of the three years in the period ended December 31, 2018, and the Corporation\u2019s internal control over financial reporting as of December 31, 2018, and have",
      "similarity": 0.5327704930612545
    }
  ],
  "How does the company with CIK 1046025 handle mine safety in 2018?": [
    {
      "cik": 1198415,
      "year": 2019,
      "section": "section_4",
      "chunk_text": "ITEM 4: MINE SAFETY DISCLOSURES Not applicable. PART II ITEM 5:",
      "similarity": 0.48524687701986313
    },
    {
      "cik": 1161154,
      "year": 2019,
      "section": "section_1A",
      "chunk_text": "part of the gas Mega Rule, the Gas Gathering Rule, focusing on requirements relating to gas gathering lines. The safety enhancement requirements and other provisions of the 2011 Pipeline Safety Act, as further amended by the 2016 Pipeline Safety Act, as well as any implementation of PHMSA rules thereunder or any issuance or reinterpretation of guidance by PHMSA or any state agencies with respect thereto, could require us to install new or modified safety controls, pursue additional capital projects, or conduct maintenance programs on an accelerated basis, any or all of which tasks could result in our incurring increased operating costs that could be significant and have a material adverse effect on our results of operations or financial condition. Our business involves the generation, handling and disposal of hazardous substances, hydrocarbons and wastes which activities are subject to environmental and worker health and safety laws and regulations that may cause us to incur",
      "similarity": 0.4743557598362485
    },
    {
      "cik": 1356949,
      "year": 2020,
      "section": "section_4",
      "chunk_text": "ITEM 4. MINE SAFETY DISCLOSURES Not applicable. SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT Name/Office Age Business Experience During Last 5 Years James L. Pokluda III President and Chief Executive Officer Chief Executive Officer since January 2012 and President since May 2011. Prior thereto, Vice President Sales & Marketing of the Company from April 2007 until May 2011. Eric W. Davis Vice President and Chief Financial Officer Vice President, Chief Financial Officer, Treasurer and Secretary since November 2020. Prior thereto, Interim Chief Financial Officer from June 2020 until November 2020, President - Heavy Lift from October 2015 until June 2020 and Vice President & Controller from December 2001 until October 2015. Jerry M. Zurovchak Senior Vice President and Chief Operating Officer Senior Vice President and Chief Operating Officer since June 2020. Prior thereto, Director, Operations from September 2019 June 2020. PART II ITEM 5.",
      "similarity": 0.45872294915453077
    }
  ],
  "What legal proceedings does the company with CIK 1046025 face in 2018?": [
    {
      "cik": 1559720,
      "year": 2020,
      "section": "section_3",
      "chunk_text": "Item 3. Legal Proceedings We are currently involved in, and may in the future be involved in, legal proceedings, claims, and government investigations in the ordinary course of business. These include proceedings, claims, and investigations relating to, among other things, regulatory matters, commercial matters, intellectual property, competition, tax, employment, pricing, discrimination, consumer rights, personal injury, and property rights. See Note 13, Commitments and Contingencies - Legal and Regulatory Matters to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. These matters also include the following: \u2022On November 23, 2020, an individual plaintiff filed a complaint asserting patent and trade secrets claims against Airbnb, Inc. in the Northern District of California. The patent at issue relates to a method of reflecting a place to stay listing in a geospatial environment. The complaint asserts direct and indirect infringement and",
      "similarity": 0.5576684658139348
    },
    {
      "cik": 931059,
      "year": 2020,
      "section": "section_15",
      "chunk_text": "Report on Form 10-Q filed with the SEC on August 13, 2020). 10.90 Form of Exchange, Redemption and Forbearance Agreement, dated as of August 31, 2020, among Rennova Health, Inc., Christopher Diamantis and the investor signatory thereto (incorporated by reference to Exhibit 10.1 of the Company\u2019s Current Report on Form 8-K filed with the SEC on September 1, 2020). List of Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 of the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on October 21, 2019). 23.1 Consent of Independent Public Accounting Firm - Haynie & Company (2) 31.1 Section 302 Certification of the Chief Executive Officer (2) 31.2 Section 302 Certification of the Interim Chief Financial Officer (2) 32.1 Section 906 Certification of the Chief Executive Officer (3) 32.2 Section 906 Certification of the Interim Chief Financial Officer (3) 101.INS XBRL Instance Document. (2) 101.SCH XBRL Taxonomy Extension Schema",
      "similarity": 0.5478147057768438
    },
    {
      "cik": 931059,
      "year": 2020,
      "section": "section_15",
      "chunk_text": "reference to Exhibit 99.5 to the Company\u2019s Amendment No. 1 to its Annual Report on Form 10-K/A filed with the SEC on June 15, 2012). 10.4 Warrant Transfer Agreement dated as of March 31, 2013 (incorporated by reference to Exhibit 10.13 to the Company\u2019s Annual Report on Form 10-K filed with the SEC on June 27, 2013). 10.5 Promissory Note issued by Tegal Corporation on July 12, 2012 to Jay M. Tenenbaum (incorporated by reference to Exhibit 10.2 to the Company\u2019s Current Report on Form 8-K filed with the SEC on July 18, 2012). 10.6 Promissory Note issued by Tegal Corporation on July 12, 2012 to CommerceNet (incorporated by reference to Exhibit 10.3 to the Company\u2019s Current Report on Form 8-K filed with the SEC on July 18, 2012). 10.7** Agreement regarding Termination of Employment, dated April 15, 2015, among CollabRx, Inc., Medytox Solutions, Inc. and Thomas R. Mika (incorporated by reference to Exhibit 10.4 of the Company\u2019s Current Report on Form 8-K filed with the SEC on April 17,",
      "similarity": 0.5390550995919884
    }
  ]
}